These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 20427856)
21. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis. Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609 [TBL] [Abstract][Full Text] [Related]
22. Secondary neutron doses for several beam configurations for proton therapy. Shin D; Yoon M; Kwak J; Shin J; Lee SB; Park SY; Park S; Kim DY; Cho KH Int J Radiat Oncol Biol Phys; 2009 May; 74(1):260-5. PubMed ID: 19362245 [TBL] [Abstract][Full Text] [Related]
23. Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantom. Bednarz B; Hancox C; Xu XG Phys Med Biol; 2009 Sep; 54(17):5271-86. PubMed ID: 19671968 [TBL] [Abstract][Full Text] [Related]
24. Out-of-field contributions for IMRT and volumetric modulated arc therapy measured using gafchromic films and compared to calculations using a superposition/convolution based treatment planning system. Van den Heuvel F; Defraene G; Crijns W; Bogaerts R Radiother Oncol; 2012 Oct; 105(1):127-32. PubMed ID: 22300610 [TBL] [Abstract][Full Text] [Related]
25. Shielding implications for secondary neutrons and photons produced within the patient during IMPT. DeMarco J; Kupelian P; Santhanam A; Low D Med Phys; 2013 Jul; 40(7):071701. PubMed ID: 23822405 [TBL] [Abstract][Full Text] [Related]
26. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer. Seco J; Gu G; Marcelos T; Kooy H; Willers H Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395 [TBL] [Abstract][Full Text] [Related]
27. Assessment of out-of-field absorbed dose and equivalent dose in proton fields. Clasie B; Wroe A; Kooy H; Depauw N; Flanz J; Paganetti H; Rosenfeld A Med Phys; 2010 Jan; 37(1):311-21. PubMed ID: 20175494 [TBL] [Abstract][Full Text] [Related]
28. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT. Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the secondary neutron field produced during treatment of an anthropomorphic phantom with x-rays, protons and carbon ions. Tessa CL; Berger T; Kaderka R; Schardt D; Burmeister S; Labrenz J; Reitz G; Durante M Phys Med Biol; 2014 Apr; 59(8):2111-25. PubMed ID: 24694920 [TBL] [Abstract][Full Text] [Related]
30. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma. Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344 [TBL] [Abstract][Full Text] [Related]
31. Secondary neutron doses received by paediatric patients during intracranial proton therapy treatments. Sayah R; Farah J; Donadille L; Hérault J; Delacroix S; De Marzi L; De Oliveira A; Vabre I; Stichelbaut F; Lee C; Bolch WE; Clairand I J Radiol Prot; 2014 Jun; 34(2):279-96. PubMed ID: 24704989 [TBL] [Abstract][Full Text] [Related]
32. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. Howell RM; Hertel NE; Wang Z; Hutchinson J; Fullerton GD Med Phys; 2006 Feb; 33(2):360-8. PubMed ID: 16532941 [TBL] [Abstract][Full Text] [Related]